Special Session Topic: Nano Based Drug Delivery Systems
Introduction: Advances in nanotechnology-based drug delivery systems
covers the core concepts and latest research regarding the
use of nanoscale materials for the development and
application of drug delivery systems. Nano-based drug
delivery systems are a class of nanomaterials that have
abilities to increase the stability and water solubility of
drugs, prolong the cycle time, increase the uptake rate of
target cells or tissues, and reduce enzyme degradation,
thereby improve the safety and effectiveness of drugs. The
special session aims to provide a forum for the discussion
about the recent developments and future prospects of nano
based drug delivery systems. The nano-sized drug delivery
have been attracted extensive attention in biomedicine,
including academics and researchers in materials science,
biomedical engineering, pharmaceutical science and related
disciplines. Contributing papers are solicited in the
following areas:
>> The synthesis, encapsulation techniques, characterization
and properties of drug delivery
>> Types of nanomaterials for drug delivery systems
>> Targeting nano based drug delivery systems
>> Multifunctional responsiveness nanocarriers
>> The application field of drug delivery systems
>> Nanotechnology in drug delivety
Submission Link: http://confsys.iconf.org/submission/icnme2024
Special Session Organizer
Assoc. Prof. Lili Feng
Harbin Engineering
University, China
Bio:
Lili Feng received her Ph.D. degree in Materials Science and
Chemical Engineering from Harbin Engineering University in
2019. She joined the Nanyang Technological University as a
postdoctoral research fellow under the supervision of Prof.
Yanli Zhao in 2019. She then obtained the Humboldt Research
Fellowship and moved to the Center For Hybrid Nanostructures
(CHyN), Universität Hamburg as a “Humboldt Scholar” with the
cooperation of Wolfgang J. Parak in 2020. In 2021, She
joined the Harbin Engineering University as an associate
Professor and received the National Youth Talent Program.
Her current research interest in developing various types of
theranostics, including research on nano-adjuvants and
delivery systems, controlled synthesis of nanomaterials and
their biological effects, and the integration of multi-modal
bioimaging technology and cancer therapy.